Foreign Bonds: 10% Return, Global Risk Due to Debt Vulnerability
In the ever-evolving global financial landscape, the US dollar has faced a significant decline in 2025, with this week's Moody's downgrade contributing to investor unease. Consequently, the Swiss Franc and Japanese Yen have witnessed a surge of more than 10% against the US Dollar, while the Euro is nearly 10% higher.
Amidst this market volatility, our Marketplace service, Hidden Dividend Stocks Plus, offers a unique opportunity. Focusing on under-the-radar, undervalued income vehicles, it seeks out high-yield situations and solid income opportunities with dividend yields ranging from 5% to 10%-plus. By examining US and international markets meticulously, we uncover strong earnings-backed income sources that can be found nowhere else.
Every week, we publish exclusive articles brimming with our latest investing insights, available solely on the HDS+ site. Learn how our carefully curated portfolio can provide fortification against market fluctuations.
Swiss Franc (CHF) Market
Boasting a robust presence in the pharma sector, Roche Holding boasts a dividend yield of approximately 3.8%-3.9%, with a 25-year record of dividend growth at 9.5% annually, albeit at a more modest 2% recently. Its strong track record, wide economic moat, and cost-effective valuation make it an intriguing choice. Similarly, Novartis offers a dividend yield of around 3.9%, backed by consistent dividend growth of 5.8% annually over 25 years. This pharmaceutical giant recently raised its dividend from CHF 3.20 to CHF 3.30.
Swiss Life Holding, with a current dividend yield around 4.22%, may be slightly underperforming its 12-month average of 4.61%. The iShares Swiss Dividend ETF, meanwhile, offers a dividend yield of about 3.46% and pays quarterly dividends in CHF, offering a diversified exposure to Swiss high-yield dividend stocks across major sectors like Financials, Health Care, and Consumer Staples.
Japanese Yen (JPY) Market
While we lack specific data on high-yield dividend stocks particular to the Japanese Yen market in 2025, traditionally, Japanese dividend aristocrats and high dividend yield sectors include large stable companies in the Utilities, Financials, and Consumer sectors, as well as dividend-focused ETFs tracking the Japanese markets for diversified exposure.
Euro (EUR) Market
Our research primarily reveals Swiss pharmaceutical companies Roche and Novartis as high dividend yield options in the Euro market, both of which have extensive operations within the Eurozone and pay dividends in CHF. These defensive sectors, with their steady dividend growth, could serve as income-generating assets in the Eurozone.
In summary, Swiss dividend stocks such as Roche and Novartis and the iShares Swiss Dividend ETF stand out as dependable, high-yield options with defensive qualities, suitable for combating market fluctuations. The Japanese and broader Euro dividend prospects would profit from further scrutiny, but sectors like utilities, healthcare, and financials tend to provide stability and yield. By blending steady dividend income with exposure to companies featuring robust economic moats and resilience to market downturns, especially in stable currency markets like CHF and EUR, investors may find an effective strategy for mitigating risk in 2025.
- In the face of market volatility caused by the US dollar's decline, our Marketplace service, Hidden Dividend Stocks Plus, presents a unique opportunity, focusing on high-yield situations and solid income opportunities with dividend yields ranging from 5% to 10%-plus.
- For those interested in the Euro market, our research has primarily revealed Swiss pharmaceutical companies Roche and Novartis as high dividend yield options, both of which have extensive operations within the Eurozone and pay dividends in CHF.
